載入...
SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery
The Primary Immune Deficiency Treatment Consortium (PIDTC) performed a retrospective analysis of 662 patients with severe combined immunodeficiency (SCID) who received a hematopoietic cell transplantation (HCT) as first-line treatment between 1982 and 2012 in 33 North American institutions. Overall...
Na minha lista:
發表在: | Blood |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
American Society of Hematology
2018
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6202916/ https://ncbi.nlm.nih.gov/pubmed/30154114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2018-03-840702 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|